Rabeprazole

Common Uses

Rabeprazole is primarily prescribed to manage conditions related to stomach acid production. It belongs to a class of drugs known as proton pump inhibitors (PPIs), which work by reducing the amount of acid the stomach produces.

Gastroesophageal Reflux Disease (GERD)

This medication is used to treat the symptoms of GERD, such as heartburn and acid reflux. It is also used to treat and maintain the healing of erosive esophagitis, which is inflammation or sores in the lining of the esophagus caused by stomach acid.

Ulcers and Infections

Rabeprazole is used for the short-term treatment and healing of duodenal ulcers. In some cases, it is used as part of a combination therapy with antibiotics to treat Helicobacter pylori (H. pylori) infections, which helps prevent ulcers from returning.

Excessive Acid Production

It is used for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome. These are rare conditions where the stomach produces an abnormally high amount of acid.

Mechanism of Action

Rabeprazole belongs to a class of medications known as proton pump inhibitors. It works by targeting the specific cells in the stomach lining that are responsible for secreting acid. These cells use an enzyme system, often referred to as the proton pump, to release acid into the stomach.

When rabeprazole is absorbed, it blocks these pumps from functioning. This action prevents the final step of acid production, leading to a significant reduction in the total amount of acid in the stomach. By lowering acid levels, the medication helps to:

• Reduce the irritation caused by acid reflux in the esophagus.
• Allow the lining of the stomach or small intestine to heal from ulcers.
• Relieve symptoms such as heartburn and persistent cough associated with acid reflux.

Because it shuts down the pumps directly, rabeprazole provides long-lasting acid suppression. This allows damaged tissues time to recover and helps prevent new damage from occurring.

Common Side Effects

The most frequently reported side effects of rabeprazole include:

• Headache
• Nausea or vomiting
• Diarrhea or constipation
• Stomach pain or gas
• Sore throat
• Dizziness

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious side effects:

• Severe diarrhea: Watery or bloody stools, stomach cramps, or fever, which may indicate a Clostridium difficile infection.
• Kidney problems: Changes in urination, blood in the urine, or swelling in the legs and feet.
• Low magnesium levels: Seizures, dizziness, irregular or fast heartbeat, jitteriness, or muscle spasms.
• Lupus-like symptoms: Joint pain or a skin rash on the cheeks or arms that worsens in sunlight.
• Vitamin B12 deficiency: Long-term use (typically over three years) may lead to symptoms such as numbness, tingling, or weakness.
• Bone fractures: An increased risk of hip, wrist, or spine fractures, especially with long-term or high-dose use.
• Allergic reactions: Rash, hives, swelling of the face or throat, or difficulty breathing.

Allergic Reactions

Rabeprazole should not be used by individuals with a known hypersensitivity to rabeprazole or other proton pump inhibitors (PPIs). Serious allergic reactions, including swelling, skin rashes, and breathing difficulties, require immediate medical attention.

Kidney and Digestive Risks

• Kidney Inflammation: Acute tubulointerstitial nephritis, a type of kidney inflammation, has been reported in patients taking PPIs. This condition can occur at any time during treatment and may lead to kidney failure.
• Severe Diarrhea: Use of this medication may increase the risk of Clostridioides difficile-associated diarrhea, especially in hospitalized patients. This condition causes watery stools, stomach pain, and fever that does not go away.

Long-Term Treatment Concerns

• Bone Fractures: Patients receiving high-dose or long-term therapy (one year or longer) may have an increased risk of hip, wrist, or spine fractures.
• Nutrient Malabsorption: Daily use for more than three years may lead to Vitamin B12 deficiency. Prolonged use is also associated with low magnesium levels (hypomagnesemia), which can cause tremors, seizures, or heart rhythm changes.
• Stomach Polyps: Long-term use increases the risk of developing fundic gland polyps, which are small growths in the upper part of the stomach.

Autoimmune Effects

The use of PPIs like rabeprazole has been linked to the development or worsening of cutaneous and systemic lupus erythematosus. Symptoms may include a rash on the arms or cheeks that worsens in sunlight, as well as joint pain.

Masking of Symptoms

While rabeprazole may improve symptoms of acid reflux or stomach pain, a positive response to the medication does not rule out the presence of stomach cancer. Healthcare providers may recommend further diagnostic testing if symptoms persist or return quickly after treatment.

Drug Interactions

Rabeprazole can interact with other medications, such as methotrexate, warfarin, and certain antiviral drugs used for HIV. These interactions may increase the risk of toxicity or affect how well the other medications work. It is important to discuss all current medications with a healthcare provider.

Pregnancy

There are no adequate and well-controlled studies of rabeprazole in pregnant women. While animal studies using high doses have not shown evidence of harm to the fetus, animal data does not always predict how a human will respond. This medication should be used during pregnancy only if a healthcare provider determines that the potential benefit justifies the potential risk to the fetus.

Breastfeeding

It is not known whether rabeprazole is excreted in human breast milk. Because many drugs are excreted in human milk and there is a potential for adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug. Patients should consult with their healthcare provider to weigh the importance of the medication to the mother against the potential risks of breastfeeding.

Available Forms

Rabeprazole is provided in the following oral dosage forms:

• Delayed-Release Tablets: These tablets are coated to ensure the medication is released at the proper time in the digestive tract. They are intended to be swallowed whole.
• Delayed-Release Capsules: These may also be referred to as sprinkle capsules. They can be swallowed whole, or for individuals who have difficulty swallowing, the capsules can be opened and the granules sprinkled onto soft food or mixed with a small amount of liquid.

FDA Approval and Indications

Rabeprazole was first approved by the U.S. Food and Drug Administration (FDA) in 1999. It is indicated for use in adults and, in some cases, pediatric patients for the following conditions:

• Healing and maintenance of erosive or ulcerative gastroesophageal reflux disease (GERD).
• Short-term treatment of symptomatic GERD.
• Healing and maintenance of duodenal ulcers.
• Long-term treatment of pathological hypersecretory conditions, such as Zollinger-Ellison syndrome.
• Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence, when used as part of a combination antibiotic regimen.

Regulatory Status and Safety Communications

Rabeprazole is available only by prescription and is not a controlled substance. There are currently no boxed warnings associated with this medication.

The FDA has issued safety communications regarding the class of drugs known as proton pump inhibitors (PPIs), which includes rabeprazole. These communications have addressed potential risks identified through post-marketing surveillance, including:

• Increased risk of Clostridioides difficile-associated diarrhea.
• Increased risk of bone fractures of the hip, wrist, or spine, particularly with long-term or high-dose use.
• Potential for low magnesium levels (hypomagnesemia) when taken for long periods.
• Reports of subacute cutaneous lupus erythematosus (SCLE) and systemic lupus erythematosus (SLE).
• Risk of acute tubulointerstitial nephritis, an immune-mediated kidney condition.

Rebound Acid Hypersecretion

When you stop taking a proton pump inhibitor (PPI) like rabeprazole, your stomach may produce more acid than it did before you started the medication. This phenomenon is known as rebound acid hypersecretion. It can cause symptoms to return, sometimes more severely than before treatment began. Common symptoms include:

• Heartburn
• Acid reflux
• Indigestion
• Stomach discomfort

Managing Discontinuation

To reduce the risk of rebound symptoms, it is important not to stop taking rabeprazole suddenly without consulting a healthcare provider. A doctor may suggest a tapering schedule to help the body adjust. Strategies for stopping the medication may include:

• Gradual tapering: Slowly reducing the dose over several weeks.
• Frequency reduction: Taking the medication every other day before stopping completely.
• Step-down therapy: Using milder medications, such as antacids or H2 blockers, to manage breakthrough symptoms during the transition period.

If you are taking rabeprazole for a specific infection, such as H. pylori, or to heal an ulcer, it is critical to complete the full course of treatment as prescribed. Stopping early in these cases may prevent the condition from healing properly or allow the infection to return.